As of Feb 27
| -0.14 / -5.98%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 5.65, with a high estimate of 5.80 and a low estimate of 5.50. The median estimate represents a +156.82% increase from the last price of 2.20.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.